FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020057069> ?p ?o ?g. }

• W2020057069 endingPage "8" @default.
• W2020057069 startingPage "1" @default.
• W2020057069 abstract "Because of improved medical therapy in contemporary practice, some have advocated that, most if not, all patients with asymptomatic carotid disease should be managed medically without intervention. Disease progression in this patient population is not well established, and data describing risk factors for disease progression in patients with moderate asymptomatic carotid artery stenosis (ASCAS) are lacking. The aim of our study was to determine the incidence of and risk factors for disease progression in this patient population.All patients presenting to a tertiary center between January 2005 and May 2012 with moderate (50-69%) ASCAS as determined by carotid artery duplex were included. Outcomes including disease progression to severe stenosis (≥70%), incidence of symptoms, need for operative intervention, and all-cause mortality were recorded. Cox proportional hazard regression models were used to identify risk factors for disease progression.A total of 282 carotid arteries in 258 patients with moderate ASCAS were identified from 1555 carotid duplex scans over the 7.5-year study period (mean age: 70.6 ± 0.55 years, 52% male). Mean follow-up time was 2.6 ± 0.10 years. Overall, disease progression to severe stenosis occurred in 25.2% (n = 71) and followed a linear trend. The incidence of symptoms including ipsilateral stroke (2.13%, n = 6) and transient ischemic attack (0.71%; n = 2) was low. Carotid endarterectomy was performed in 15.3% (n = 43) of patients, all with severe disease. Carotid stenting was performed in 3.90% (n = 11) patients. Risk of progression was higher in patients receiving dual antiplatelet therapy (Hazard Ratio [HR] 1.85, 95% confidence interval [CI] 1.09-3.15; P = 0.02) and smokers (HR 1.85, 95% CI 0.96-3.55; P = 0.05). Age, gender (women), hypertension, statin use, and aspirin use were not significant predictors of progression to severe stenosis. There was a nonsignificant trend toward increased mortality in patients who progressed compared with those who did not (HR 3.39, 95% CI 0.91-12.6; P = 0.07).In our study, one-quarter of patients with moderate ASCAS progressed to severe disease, although the majority remained asymptomatic. Smoking and dual antiplatelet therapy are independent risk factors for disease progression. Patients with identifiable risk factors may warrant more careful follow-up." @default.
• W2020057069 created "2016-06-24" @default.
• W2020057069 creator A5004226487 @default.
• W2020057069 creator A5023466823 @default.
• W2020057069 creator A5028214996 @default.
• W2020057069 creator A5040314151 @default.
• W2020057069 creator A5040413707 @default.
• W2020057069 creator A5060417448 @default.
• W2020057069 creator A5080751473 @default.
• W2020057069 creator A5081871306 @default.
• W2020057069 creator A5089766698 @default.
• W2020057069 date "2015-01-01" @default.
• W2020057069 modified "2023-09-23" @default.
• W2020057069 title "Risk of Disease Progression in Patients with Moderate Asymptomatic Carotid Artery Stenosis: Implications of Tobacco Use and Dual Antiplatelet Therapy" @default.
• W2020057069 cites W1607765623 @default.
• W2020057069 cites W1740376762 @default.
• W2020057069 cites W1964413620 @default.
• W2020057069 cites W1965408926 @default.
• W2020057069 cites W1966564237 @default.
• W2020057069 cites W1966642327 @default.
• W2020057069 cites W1967200642 @default.
• W2020057069 cites W1987335375 @default.
• W2020057069 cites W1990387170 @default.
• W2020057069 cites W1996926581 @default.
• W2020057069 cites W2004696591 @default.
• W2020057069 cites W2011051117 @default.
• W2020057069 cites W2012418658 @default.
• W2020057069 cites W2012958001 @default.
• W2020057069 cites W2018417882 @default.
• W2020057069 cites W2029088929 @default.
• W2020057069 cites W2036397809 @default.
• W2020057069 cites W2044568203 @default.
• W2020057069 cites W2046213632 @default.
• W2020057069 cites W2055707969 @default.
• W2020057069 cites W2070156228 @default.
• W2020057069 cites W2084942406 @default.
• W2020057069 cites W2088520754 @default.
• W2020057069 cites W2122528416 @default.
• W2020057069 cites W2128616793 @default.
• W2020057069 cites W2137950095 @default.
• W2020057069 cites W2139580847 @default.
• W2020057069 cites W2147267416 @default.
• W2020057069 cites W2152662337 @default.
• W2020057069 cites W2152958364 @default.
• W2020057069 cites W2158791553 @default.
• W2020057069 cites W2170776558 @default.
• W2020057069 cites W2191706483 @default.
• W2020057069 cites W2216101174 @default.
• W2020057069 cites W2328688825 @default.
• W2020057069 cites W2767911074 @default.
• W2020057069 cites W2949679206 @default.
• W2020057069 cites W4211201192 @default.
• W2020057069 cites W4324264875 @default.
• W2020057069 doi "https://doi.org/10.1016/j.avsg.2014.02.007" @default.
• W2020057069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24530720" @default.
• W2020057069 hasPublicationYear "2015" @default.
• W2020057069 type Work @default.
• W2020057069 sameAs 2020057069 @default.
• W2020057069 citedByCount "17" @default.
• W2020057069 countsByYear W20200570692014 @default.
• W2020057069 countsByYear W20200570692015 @default.
• W2020057069 countsByYear W20200570692016 @default.
• W2020057069 countsByYear W20200570692017 @default.
• W2020057069 countsByYear W20200570692018 @default.
• W2020057069 countsByYear W20200570692019 @default.
• W2020057069 countsByYear W20200570692020 @default.
• W2020057069 countsByYear W20200570692021 @default.
• W2020057069 countsByYear W20200570692023 @default.
• W2020057069 crossrefType "journal-article" @default.
• W2020057069 hasAuthorship W2020057069A5004226487 @default.
• W2020057069 hasAuthorship W2020057069A5023466823 @default.
• W2020057069 hasAuthorship W2020057069A5028214996 @default.
• W2020057069 hasAuthorship W2020057069A5040314151 @default.
• W2020057069 hasAuthorship W2020057069A5040413707 @default.
• W2020057069 hasAuthorship W2020057069A5060417448 @default.
• W2020057069 hasAuthorship W2020057069A5080751473 @default.
• W2020057069 hasAuthorship W2020057069A5081871306 @default.
• W2020057069 hasAuthorship W2020057069A5089766698 @default.
• W2020057069 hasConcept C120665830 @default.
• W2020057069 hasConcept C121332964 @default.
• W2020057069 hasConcept C126322002 @default.
• W2020057069 hasConcept C127413603 @default.
• W2020057069 hasConcept C141071460 @default.
• W2020057069 hasConcept C164705383 @default.
• W2020057069 hasConcept C207103383 @default.
• W2020057069 hasConcept C2776184368 @default.
• W2020057069 hasConcept C2777910003 @default.
• W2020057069 hasConcept C2778213512 @default.
• W2020057069 hasConcept C2779169563 @default.
• W2020057069 hasConcept C2779745121 @default.
• W2020057069 hasConcept C2780007028 @default.
• W2020057069 hasConcept C2780645631 @default.
• W2020057069 hasConcept C2781068581 @default.
• W2020057069 hasConcept C2908647359 @default.
• W2020057069 hasConcept C44249647 @default.
• W2020057069 hasConcept C50382708 @default.
• W2020057069 hasConcept C61511704 @default.
• W2020057069 hasConcept C71924100 @default.

• next